Look out, Teva: Mylan's Copaxone copy has already captured serious share
admin 4th January 2018 Uncategorised 0Mylan’s long-acting Copaxone copy won FDA approval just three months ago, but it’s already gobbled up a sizable chunk of Teva’s market share.
More: Look out, Teva: Mylan's Copaxone copy has already captured serious share
Source: fierce